TG Therapeutics (TGTX) Short Interest Ratio & Short Volume $33.32 -0.25 (-0.74%) (As of 09:46 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends TG Therapeutics Short Interest DataTG Therapeutics (TGTX) has a short interest of 29.08 million shares, representing 20.71% of the float (the number of shares available for trading by the public). This marks a 2.65% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.1, indicating that it would take 8.1 days of the average trading volume of 3.59 million shares to cover all short positions.Current Short Interest29,080,000 sharesPrevious Short Interest28,330,000 sharesChange Vs. Previous Month+2.65%Dollar Volume Sold Short$1.01 billionShort Interest Ratio8.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares155,665,000 sharesFloat Size140,420,000 sharesShort Percent of Float20.71%Today's Trading Volume91,147 sharesAverage Trading Volume3,586,202 sharesToday's Volume Vs. Average3% Short Selling TG Therapeutics? Sign up to receive the latest short interest report for TG Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTGTX Short Interest Over TimeTGTX Days to Cover Over TimeTGTX Percentage of Float Shorted Over Time Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW TG Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/202429,080,000 shares $1.01 billion +2.7%20.7%8.1 $34.80 11/15/202428,330,000 shares $836.87 million -11.5%20.2%7.5 $29.54 10/31/202432,000,000 shares $801.92 million -1.5%23.1%8.9 $25.06 10/15/202432,480,000 shares $798.03 million -5.6%23.5%9.2 $24.57 9/30/202434,400,000 shares $804.62 million +15.3%24.9%9.5 $23.39 9/15/202429,840,000 shares $708.10 million +1.1%21.6%8.2 $23.73 Get the Latest News and Ratings for TGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for TG Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/202429,510,000 shares $693.19 million -9.8%21.4%9.6 $23.49 8/15/202432,720,000 shares $685.16 million +5.0%23.7%11.4 $20.94 7/31/202431,170,000 shares $615.92 million -3.1%22.6%11.2 $19.76 7/15/202432,180,000 shares $684.47 million -1.6%23.4%10.4 $21.27 6/30/202432,700,000 shares $581.73 million -2.6%23.8%10.6 $17.79 6/15/202433,560,000 shares $555.42 million +0.6%24.4%11 $16.55 5/31/202433,350,000 shares $543.61 million -2.8%24.2%10.9 $16.30 5/15/202434,300,000 shares $607.80 million -9.4%24.9%9.4 $17.72 4/30/202437,850,000 shares $517.03 million +6.0%27.1%10 $13.66 4/15/202435,710,000 shares $502.44 million +3.9%25.6%10.3 $14.07 3/31/202434,360,000 shares $522.62 million +0.5%24.7%7.9 $15.21 3/15/202434,190,000 shares $520.37 million -1.9%24.5%7.2 $15.22 2/29/202434,840,000 shares $599.94 million -2.6%25.0%6.7 $17.22 2/15/202435,780,000 shares $515.23 million +22.9%26.2%7.2 $14.40 1/31/202429,120,000 shares $472.91 million -5.2%21.4%5.6 $16.24 1/15/202430,700,000 shares $484.14 million -3.6%22.5%4.7 $15.77 12/31/202331,830,000 shares $543.66 million -12.8%23.2%5.2 $17.08 12/15/202336,520,000 shares $674.89 million +1.7%26.6%6.3 $18.48 11/30/202335,920,000 shares $460.14 million -1.9%26.2%6.4 $12.81 11/15/202336,610,000 shares $412.59 million -1.1%26.7%6.8 $11.27 10/31/202337,020,000 shares $286.16 million -0.5%27.0%6.8 $7.73 10/15/202337,210,000 shares $248.93 million +14.5%27.2%7.2 $6.69 9/30/202332,510,000 shares $271.78 million +10.2%23.7%6.5 $8.36 9/15/202329,510,000 shares $299.23 million +5.5%21.5%6 $10.14 8/31/202327,970,000 shares $292.85 million +1.6%20.4%5.8 $10.47 8/15/202327,520,000 shares $317.31 million +19.2%20.1%5.8 $11.53 7/31/202323,080,000 shares $477.53 million +3.3%16.9%5 $20.69 7/15/202322,340,000 shares $493.71 million -1.1%16.5%5.7 $22.10 6/30/202322,580,000 shares $560.89 million +0.4%16.7%5.5 $24.84 6/15/202322,480,000 shares $595.27 million +0.2%16.6%5.4 $26.48 5/31/202322,430,000 shares $597.31 million +3.0%16.6%5.2 $26.63 5/15/202321,770,000 shares $678.14 million -15.0%16.1%5.1 $31.15 4/30/202325,610,000 shares $635.90 million -6.7%19.3%5.8 $24.83 4/15/202327,460,000 shares $557.99 million -3.4%20.7%6.6 $20.32Vacuum up cash with these special trades? (Ad)Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. 3/31/202328,420,000 shares $427.44 million +6.6%21.5%6.3 $15.04 3/15/202326,650,000 shares $394.15 million +2.6%20.1%4.7 $14.79 2/28/202325,970,000 shares $416.04 million +6.3%19.1%4.6 $16.02 2/15/202324,440,000 shares $472.67 million +4.2%18.1%4.5 $19.34 1/31/202323,450,000 shares $357.14 million +4.0%17.4%4.3 $15.23 1/15/202322,560,000 shares $307.49 million -3.3%16.7%4.4 $13.63 12/30/202223,340,000 shares $276.11 million +12.9%17.3%4.9 $11.83 12/15/202220,680,000 shares $178.26 million +6.9%15.3%7 $8.62 11/30/202219,350,000 shares $170.67 million -1.7%14.4%7.2 $8.82 11/15/202219,680,000 shares $173.38 million +2.3%14.6%7.6 $8.81 10/31/202219,230,000 shares $111.92 million -1.1%14.3%7.9 $5.82 10/15/202219,440,000 shares $105.56 million +5.8%14.5%7.6 $5.43 9/30/202218,380,000 shares $108.81 million +3.8%13.7%7 $5.92 9/15/202217,710,000 shares $129.28 million -3.1%13.2%6.6 $7.30 8/31/202218,270,000 shares $130.27 million -3.5%13.6%6.3 $7.13 8/15/202218,940,000 shares $159.10 million -7.1%14.1%5.9 $8.40 7/31/202220,380,000 shares $122.08 million -2.3%15.3%6.2 $5.99 7/15/202220,860,000 shares $129.33 million +0.2%28.8%6.6 $6.20 6/30/202220,810,000 shares $88.44 million +2.5%28.7%6.3 $4.25 6/15/202220,310,000 shares $78.60 million +5.6%28.0%6.4 $3.87 5/31/202219,240,000 shares $85.04 million -2.6%14.4%6.5 $4.42 5/15/202219,760,000 shares $128.44 million +1.2%14.8%7.8 $6.50 4/30/202219,530,000 shares $135.54 million +0.8%14.8%8.3 $6.94 4/15/202219,370,000 shares $171.42 million -8.1%14.6%6.9 $8.85 3/31/202221,070,000 shares $200.38 million +11.0%15.9%8.5 $9.51 3/15/202218,980,000 shares $151.65 million -3.8%14.3%7.8 $7.99 2/28/202219,720,000 shares $194.64 million +4.0%14.9%8.4 $9.87 2/15/202218,970,000 shares $207.34 million +13.9%14.3%7.1 $10.93 1/31/202216,660,000 shares $192.76 million +2.0%12.5%6.4 $11.57 1/15/202216,340,000 shares $256.37 million +6.4%12.3%8.6 $15.69 12/31/202115,360,000 shares $291.84 million +5.8%N/A8.8 $19.00 12/15/202114,520,000 shares $242.77 million +8.5%11.0%8.9 $16.72 11/30/202113,380,000 shares $203.38 million -1.2%10.1%8.7 $15.20 11/15/202113,540,000 shares $366.26 million +0.6%10.2%11.6 $27.05 10/29/202113,460,000 shares $420.22 million -1.7%10.2%10.7 $31.22 10/15/202113,690,000 shares $456.01 million +1.3%10.4%9.1 $33.31 9/30/202113,520,000 shares $449.95 million +4.1%10.2%8.9 $33.28 9/15/202112,990,000 shares $388.40 million -6.2%9.8%8.6 $29.90 8/31/202113,850,000 shares $374.92 million +8.0%10.5%9.4 $27.07 8/13/202112,820,000 shares $292.17 million +12.2%9.7%9.2 $22.79 7/30/202111,430,000 shares $399.94 million +3.5%8.7%8.6 $34.99 7/15/202111,040,000 shares $411.02 million +2.5%8.4%9.8 $37.23 6/30/202110,770,000 shares $417.77 million -5.8%8.2%8.5 $38.79 6/15/202111,430,000 shares $427.60 million -2.8%8.7%8.3 $37.41 5/28/202111,760,000 shares $410.07 million +1.8%8.9%8.3 $34.87 5/14/202111,550,000 shares $395.47 million +2.6%8.8%8 $34.24 4/30/202111,260,000 shares $484.41 million +0.8%8.5%7.7 $43.02 4/15/202111,170,000 shares $497.85 million -5.4%8.5%7.5 $44.57 3/31/202111,810,000 shares $534.76 million -1.3%9.0%8.1 $45.28 3/15/202111,960,000 shares $595.97 million +1.0%9.1%7.9 $49.83Vacuum up cash with these special trades? (Ad)Have you ever heard about a “volatility vacuum?” Most people haven’t. It all revolves around this formula right here. Now, the most important thing is that this equation — when applied to certain tickers at a certain time each month —- can trigger these “volatility vacuums.” And when that happens, anyone has the shot at sucking out payouts of $290, $350, even $1,350 in as little as 24 hours. (With just a $1k starting stake!) Granted, there were smaller wins and those that did not work out but best of all, we can know exactly when these opportunities will hit. I’ve used this info to create a Cash Calendar that lays out the precise dates of these payouts. And I’m sending it for FREE to anyone who joins me during my FREE training right here. 2/26/202111,840,000 shares $515.04 million +0.7%9.1%5.7 $43.50 2/12/202111,760,000 shares $574.01 million -2.1%9.2%5.8 $48.81 1/29/202112,010,000 shares $577.08 million -4.4%9.4%5.9 $48.05 1/15/202112,560,000 shares $642.95 million No Change9.8%6.3 $51.19 1/31/202013,860,000 shares $196.95 million +7.8%16.1%6.4 $14.21 1/15/202013,860,000 shares $195.43 million +7.8%16.1%6.4 $14.10 12/31/201912,860,000 shares $142.75 million +0.9%14.9%6.6 $11.10 TGTX Short Interest - Frequently Asked Questions What is TG Therapeutics' current short interest? Short interest is the volume of TG Therapeutics shares that have been sold short but have not yet been covered or closed out. As of November 30th, traders have sold 29,080,000 shares of TGTX short. 20.71% of TG Therapeutics' shares are currently sold short. Learn More on TG Therapeutics' current short interest. What is a good short interest ratio for TG Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TGTX shares currently have a short interest ratio of 8.0. Learn More on TG Therapeutics's short interest ratio. Which institutional investors are shorting TG Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of TG Therapeutics: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Walleye Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for TG Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.71% of TG Therapeutics' floating shares are currently sold short. Is TG Therapeutics' short interest increasing or decreasing? TG Therapeutics saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 29,080,000 shares, an increase of 2.6% from the previous total of 28,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is TG Therapeutics' float size? TG Therapeutics currently has issued a total of 155,665,000 shares. Some of TG Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TG Therapeutics currently has a public float of 140,420,000 shares. How does TG Therapeutics' short interest compare to its competitors? 20.71% of TG Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to TG Therapeutics: Teva Pharmaceutical Industries Limited (1.98%), BeiGene, Ltd. (1.37%), Moderna, Inc. (11.90%), Viatris Inc. (1.78%), Summit Therapeutics Inc. (2.28%), Genmab A/S (0.32%), Dr. Reddy's Laboratories Limited (1.32%), Sarepta Therapeutics, Inc. (6.09%), Catalent, Inc. (8.12%), Vaxcyte, Inc. (8.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short TG Therapeutics stock? Short selling TGTX is an investing strategy that aims to generate trading profit from TG Therapeutics as its price is falling. TGTX shares are trading down $0.83 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against TG Therapeutics? A short squeeze for TG Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TGTX, which in turn drives the price of the stock up even further. How often is TG Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TGTX, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Teva Pharmaceutical Industries Short Interest BeiGene Short Interest Moderna Short Interest Viatris Short Interest Summit Therapeutics Short Interest Genmab A/S Short Interest Dr. Reddy's Laboratories Short Interest Sarepta Therapeutics Short Interest Catalent Short Interest Vaxcyte Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TGTX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored50-year Wall Street legend: “Sell this tech stock NOW”Something very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TGTX Stock Alerts